Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria M Gager

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Thrombosis Journal|April 15, 2022
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trialGeorg Gelbenegger, Juergen Grafeneder, Gloria M Gager, et al.
Biomedicines|May 16, 2023
Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary SyndromeGloria M Gager, Ceren Eyileten, Marek Postuła, et al.
European Journal of Cancer Care|May 31, 2019
Patients' attitude and knowledge towards resuscitation and advance care planning at the palliative care unitMatthias Unseld, Gloria M Gager, Feroniki Adamidis, et al.
Frontiers in Cardiovascular Medicine|July 25, 2022
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel DiseaseGloria M Gager, Ceren Eyileten, Marek Postula, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-AnalysisGeorg Gelbenegger, Christian Schoergenhofer, Bernd Jilma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2021
Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart FailureGloria M Gager, Dirk von Lewinski, Harald Sourij, et al.
Vascular Pharmacology|October 9, 2020
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndromeGloria M Gager, Benedikt Biesinger, Felix Hofer, et al.
International Journal of Cardiology|November 4, 2024
The interaction between non-coding RNAs and SGLT2: A reviewJoanna Jarosz-Popek, Ceren Eyileten, Gloria M Gager, et al.
JACC. Cardiovascular Interventions|December 24, 2021
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-AnalysisMatthias Bogyi, Rüdiger E Schernthaner, Christian Loewe, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Thrombosis Journal|April 15, 2022
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trialGeorg Gelbenegger, Juergen Grafeneder, Gloria M Gager, et al.
Biomedicines|May 16, 2023
Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary SyndromeGloria M Gager, Ceren Eyileten, Marek Postuła, et al.
European Journal of Cancer Care|May 31, 2019
Patients' attitude and knowledge towards resuscitation and advance care planning at the palliative care unitMatthias Unseld, Gloria M Gager, Feroniki Adamidis, et al.
Frontiers in Cardiovascular Medicine|July 25, 2022
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel DiseaseGloria M Gager, Ceren Eyileten, Marek Postula, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-AnalysisGeorg Gelbenegger, Christian Schoergenhofer, Bernd Jilma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2021
Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart FailureGloria M Gager, Dirk von Lewinski, Harald Sourij, et al.
Vascular Pharmacology|October 9, 2020
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndromeGloria M Gager, Benedikt Biesinger, Felix Hofer, et al.
International Journal of Cardiology|November 4, 2024
The interaction between non-coding RNAs and SGLT2: A reviewJoanna Jarosz-Popek, Ceren Eyileten, Gloria M Gager, et al.
JACC. Cardiovascular Interventions|December 24, 2021
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-AnalysisMatthias Bogyi, Rüdiger E Schernthaner, Christian Loewe, et al.
Pageof 2